A. Langone

发表

Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients

P. Bolin, B. Tanriover, G. Zibari, 2007, Transplantation.

Ezetimibe Reduces Low-Density Lipoprotein Cholesterol (LDL-C) in Renal Transplant Patients Resistant to HMG-CoA Reductase Inhibitors

A. Langone, P. Chuang, 2007, American journal of therapeutics.

Ezetimibe in Renal Transplant Patients with Hyperlipidemia Resistant to HMG-CoA Reductase Inhibitors

A. Langone, P. Chuang, 2006, Transplantation.

Drugs in development for prophylaxis of rejection in kidney-transplant recipients

A. Langone, M. Sanders, 2015 .

Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients

Patty W. Wright, A. Langone, K. Schlendorf, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

End-Stage Renal Failure in the Diabetic Patient

A. Langone, J. Giullian, 2008 .

Non-immunoglobulin A mesangial immune complex glomerulonephritis in kidney transplants.

A. Fogo, A. Langone, G. Giannico, 2015, Human pathology.

Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis

A. Fogo, A. Langone, D. Lenihan, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

The effect of pulsatile pump perfusion on hepatitis C transmission in kidney transplantation: a prospective pilot study.

A. Langone, H. Schaefer, D. Shaffer, 2020, Clinical transplantation.

Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation

D. Brennan, A. Djamali, M. Weir, 2021, Kidney360.

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients

J. Sninsky, A. Matas, A. Langone, 2018, Transplantation direct.

mTOR inhibitor‐associated dermatologic and mucosal problems

J. D. de Fijter, E. Stockfleth, J. Campistol, 2010, Clinical transplantation.

Homeostasis of Solute and Water by the Transplanted Kidney

A. Langone, J. Helderman, H. Schaefer, 2013 .

CHAPTER 97 – Homeostasis of Solute and Water by the Transplanted Kidney

A. Langone, J. Helderman, H. Schaefer, 2008 .

Identifying and addressing potentially preventable causes of renal allograft loss.

A. Langone, J. Helderman, 2002, Kidney international.

Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients Experiencing Gastrointestinal Intolerance: A Multicenter, Double-Blind, Randomized Study

P. Bolin, L. Chan, M. Cooper, 2011, Transplantation.

Mammalian target of rapamycin inhibitors in organ transplantation: an unkept promise.

A. Langone, J. Helderman, J. Helderman, 2012, Chest.

Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications.

A. Langone, I. Feurer, J. Helderman, 2006, Transplantation proceedings.

Short-term results under three different immunosuppressive regimens at one center.

A. Langone, I. Feurer, J. Helderman, 2006, Transplantation proceedings.

Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreement.

Leena Choi, A. Langone, A. Zuckerman, 2021, Journal of the American Pharmacists Association : JAPhA.

Disparity between solid-organ supply and demand.

A. Langone, J. Helderman, 2003, The New England journal of medicine.

Experience with cyclosporine.

A. Langone, J. Helderman, 2004, Transplantation proceedings.

Assessing Long‐Term Nephron Loss: Is It Time to Kick the CAN Grading System?

P. Halloran, B. Kaplan, A. Langone, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers

A. Langone, C. Parikh, P. Chuang, 2005, Clinical transplantation.

Thin Glomerular Basement Membrane in a Kidney Transplant of an Alport's Syndrome Patient: A Case Report.

T. Golper, A. Fogo, A. Langone, 2017, Transplantation proceedings.

Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry

O. Pankewycz, L. Chan, A. Langone, 2012, Clinical transplantation.

Acute Rejection of a Kidney Transplant in a Patient With Common Variable Immunodeficiency: A Case Report.

J. Fahrenholz, A. Langone, P. Paueksakon, 2017, Transplantation proceedings.

Long‐term dosing patterns of enteric‐coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation

O. Pankewycz, L. Chan, A. Langone, 2014, Clinical transplantation.

Cell-Free DNA and Active Rejection in Kidney Allografts.

J. Sninsky, A. Matas, D. Brennan, 2017, Journal of the American Society of Nephrology.

Clobetasol Ameliorates Aphthous Ulceration in Renal Transplant Patients on Sirolimus

A. Langone, P. Chuang, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Polyclonal Antibody-Induced Serum Sickness in Renal Transplant Recipients: Treatment with Therapeutic Plasma Exchange

B. Tanriover, A. Langone, J. Helderman, 2005, Transplantation.

Unexpected Race and Ethnicity Differences in the U.S. National Veterans Affairs Kidney Transplant Program.

S. Saha, M. Dew, L. Myaskovsky, 2019, Transplantation.

Has the Department of Veterans Affairs Found a Way to Avoid Racial Disparities in the Evaluation Process for Kidney Transplantation?

S. Saha, M. Dew, L. Myaskovsky, 2017, Transplantation.

The Management of the Failed Renal Allograft: An Enigma with Potential Consequences

A. Langone, P. Chuang, 2005, Seminars in dialysis.

How Should We Manage Renal Transplant Patients with Failed Allografts Who Return to Dialysis?

A. Langone, Guneet S. Kochar, 2020, Blood Purification.

Effect of Renal Transplantation on Biomarkers of Inflammation and Oxidative Stress in End-Stage Renal Disease Patients

J. Morrow, T. Ikizler, J. Himmelfarb, 2005, Transplantation.

Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.

S. Phillips, A. Kassim, A. Langone, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP‐TacrO (STRATO): an open‐label, multicenter, prospective phase 3b study

K. Sethi, J. Morgan, A. Matas, 2015, Clinical transplantation.

IgA-Dominant Acute Postinfectious Glomerulonephritis Presenting as Acute Renal Failure in a Kidney Transplant Recipient

Mark A. Lusco, T. Thayer, J. Arroyo, 2017, Kidney international reports.

Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications.

J. Sninsky, A. Matas, D. Brennan, 2017, The journal of applied laboratory medicine.

Recurrent pauci-immune necrotizing crescentic glomerulonephritis in a kidney transplant patient.

A. Fogo, A. Langone, J. Helderman, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal donation after cardiac death.

A. Langone, N. Shah, 2010, Journal of the American Society of Nephrology : JASN.

Effects of diabetes and cadaveric organs on functional performance and health-related quality of life after kidney transplantation.

T. Speroff, C. Pinson, A. Langone, 2003, American journal of surgery.

Kidney transplantation in a veterans administration medical center: 40 years' experience.

A. Langone, J. Helderman, W. Nylander, 2004, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE) study.

L. Chan, A. Langone, M. Chisholm-Burns, 2014, Annals of transplantation.

A young man with 20 years of nephrotic range proteinuria without loss of renal function.

A. Fogo, A. Langone, M. Revelo, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The effect of pancreas transplantation on cardiovascular mortality.

A. Langone, J. Helderman, 2001, Kidney International.

A pilot protocol of a calcineurin‐inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function

A. Langone, J. Helderman, W. Nylander, 2003, Clinical transplantation.

Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting

K. Birdwell, A. Langone, M. Kapp, 2021, Transplantation direct.

Living donor kidney transplantation in a Veterans Administration medical center.

A. Langone, J. Helderman, W. Nylander, 2004, American journal of surgery.

Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications.

J. Sninsky, A. Matas, D. Brennan, 2017, The journal of applied laboratory medicine.